Influenza

An easy weekly spray up the nose has become a contender for being a first-in-class treatment for protection from respiratory viruses, including the flu. And the startup advancing this breakthrough is heavily backed by the US Department of Defense.

Scientists have uncovered a new pathogen transmitted to humans by ticks, reminding us that one of the biggest threats to our health is zoonotic diseases. The upside is that the more we know, the better our survival odds become.

In somewhat of a surprise announcement, the Food and Drug Administration has approved the first US influenza vaccine engineered from the mRNA technology that gave us one of the most administered COVID-19 shots during the pandemic.